Sign up
Quantellect · Congress · Congressional Trade

Kevin Hern bought EXACT Sciences Corporation (NASDAQ: EXAS)

Kevin Hern bought EXACT Sciences Corporation (EXAS), disclosed June 15, 2021

Kevin Hern bought EXAS · disclosed June 15, 2021

Kevin Hern, a OK House member representing District 1, purchased $1,001 - $15,000 of EXACT Sciences Corporation (EXAS) on May 20, 2021. Filings associated with Kevin Hern disclosed 1 other EXAS transaction (1 purchase) in the 12 months before this trade. Shares of EXAS have risen 8.8% since the first observed purchase on July 27, 2020. The filing was publicly disclosed on June 15, 2021; a direct filing link is not available in the current data record.

Follow this and other congressional disclosures on the Quantellect congress trading dashboard. For Kevin Hern's complete filing history, visit Kevin Hern's full trade history. Browse all trading members of Congress tracked by Quantellect.

Key points

  • Kevin Hern bought EXAS in the amount range of $1,001 - $15,000 on May 20, 2021, filed under the STOCK Act.
  • The filing lists Dependent child as the transaction owner and was disclosed 26 days after the trade.
  • The asset description in the filing reads 'Exact Sciences Corporation (EXAS) [ST] F ILING S TATUS : New S UBHOLDING O F : Kelby Austin Hern Trust D ESCRIPTION : buy.'
  • Filings associated with Kevin Hern disclosed 1 other EXAS transaction (1 purchase) in the 12 months before this trade.
  • Shares of EXAS have risen 8.8% since the first observed purchase on July 27, 2020.

Did Kevin Hern buy or sell EXAS?

The Periodic Transaction Report covers a single purchase involving EXAS on May 20, 2021. The filed amount range is $1,001 - $15,000. The asset description reads 'Exact Sciences Corporation (EXAS) [ST] F ILING S TATUS : New S UBHOLDING O F : Kelby Austin Hern Trust D ESCRIPTION : buy', as submitted by the filer. The report was submitted on June 15, 2021. Under the STOCK Act, covered transactions generally must be reported within 30 days of receiving notice and no later than 45 days after the transaction.

PoliticianActionTickerAmountTrade dateFiled
Kevin Hern (House)BuyEXAS$1,001 - $15,000May 20, 2021June 15, 2021

What other EXAS trades has Kevin Hern disclosed in the past 12 months?

Filings associated with Kevin Hern disclosed 1 other EXAS transaction (1 purchase) in the 12 months before this trade.

Trade dateActionOwnerAmountFiling
July 27, 2020BuyJoint$1,001 - $15,000Filing unavailable

What does the filing show, and what does it not show?

The filing reports a purchase involving EXAS by Kevin Hern in the amount range of $1,001 - $15,000, with Dependent child listed as the owner. It does not establish Kevin Hern's total holdings in EXAS, any realized profit or loss, the reasons for the transaction, or any committee connection. The asset description reads 'Exact Sciences Corporation (EXAS) [ST] F ILING S TATUS : New S UBHOLDING O F : Kelby Austin Hern Trust D ESCRIPTION : buy', as submitted by the filer; that label is reproduced without adding a legal or regulatory interpretation. Quantellect's current profile data does not identify Kevin Hern's committee assignments, so this article draws no connection between the trade and any legislative jurisdiction. Filings associated with Kevin Hern disclosed 1 other EXAS transaction (1 purchase) in the 12 months before this trade. Quantellect tracks how disclosed purchases have performed, but does not treat corporate actions as buys or sells.

Who else in Congress traded EXAS?

Quantellect's current database lists these recent EXAS disclosures by other members. Owner labels come from the native filing row; an official filing link appears only when it is available in the source data.

MemberPartyActionAmountDisclosed
No recent disclosures by other members are available.

How has Kevin Hern's disclosed trading performed?

Kevin Hern holds a Quantellect Member Score of 39 (mixed), a descriptive rating of disclosed congressional buys over the trailing 24 months, based on estimated, unrealized results from filed amount ranges and closing prices.

Member Score rank #46 of 74 rated members. The rating covers buys only: entry uses the transaction-date close, positions are marked to the latest close, and dollar figures are estimates from the disclosed ranges, not realized gains. It describes disclosed activity and is not investment advice.

All Kevin Hern EXAS trades

TradedTypeSizeReturnEst. profit
March 24, 2026Sell$1,001 - $15,000N/A—
January 2, 2024Sell$1,001 - $15,000N/A—
January 31, 2023Sell$1,001 - $15,000N/A—
December 19, 2022Sell$50,001 - $100,000N/A—
May 16, 2022Sell$1,001 - $15,000N/A—
May 20, 2021Buy$1,001 - $15,000N/A-$63
May 20, 2021Buy$50,001 - $100,000N/A-$589
May 20, 2021Buy$1,001 - $15,000N/A-$63
May 20, 2021Buy$1,001 - $15,000N/A-$63
July 27, 2020Buy$1,001 - $15,000N/A+$707

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Frequently asked questions

Did Kevin Hern buy or sell EXAS?

According to the disclosure, Kevin Hern purchased EXAS on May 20, 2021.

What amount was reported for the EXAS transaction?

The disclosure reports $1,001 - $15,000 for the purchase. Filed amounts are ranges, not exact transaction values.

When did the transaction occur, and when was it disclosed?

The transaction is dated May 20, 2021, and it was disclosed on June 15, 2021.

Where can I see Kevin Hern's other congressional trades?

Quantellect lists Kevin Hern's complete disclosed trade history on the member profile. Kevin Hern's trade history

Is congressional stock trading legal?

The STOCK Act does not impose a blanket ban on members holding or trading individual securities. It requires public disclosure of covered transactions, generally within 30 days of receiving notice and no later than 45 days after the transaction. Other laws and chamber rules may also apply. STOCK Act

Is Congress exempt from insider trading laws?

No. The STOCK Act expressly affirms that members and congressional employees are not exempt from federal insider-trading prohibitions and owe a duty arising from their positions. Public disclosure is a separate obligation and does not shield a trade from those laws. STOCK Act

How quickly must members of Congress disclose a trade?

Under the STOCK Act, a covered transaction generally must be reported on a Periodic Transaction Report within 30 days of receiving notice and no later than 45 days after the transaction. House Ethics guidance describes the reporting schedule and applicable late-filing fee. House Ethics PTR guidance

How is net worth reported in these disclosures?

It is not. STOCK Act filings report transaction and asset ranges, not a complete or real-time net worth. Quantellect does not estimate a member's net worth from these filings; any third-party estimate is not part of the official disclosure. STOCK Act

Like this article? Share it
Methodology & disclaimer. Trades reflect Periodic Transaction Reports filed under the STOCK Act of 2012, which requires members of Congress to disclose covered transactions, generally within 30 days of receiving notice of the transaction and no later than 45 days after the transaction; disclosed amounts are the broad ranges in the official filing, not exact figures. Estimated prices and post-trade returns are derived from end-of-day market data and may be revised as filings are amended. The Member Score measures a member's disclosed-trade track record against a sector-matched benchmark. This article is generated programmatically for education and research only. It is not investment advice, a recommendation, or an allegation of unlawful trading.

Trades reflect disclosures filed under the STOCK Act and are provided for informational purposes only, not investment advice. Amounts are ranges from official filings; estimated prices and post-trade returns are derived from end-of-day market data and may be revised as filings are amended.